Matt Phipps
Stock Analyst at William Blair
(2.06)
# 3,067
Out of 4,402 analysts
548
Total ratings
40.3%
Success rate
0.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matt Phipps
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Maintained: Hold | n/a | $107.83 | - | 44 | Jun 11, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | n/a | $10.91 | - | 12 | Jun 11, 2026 | |
| EVMN Evommune | Maintained: Buy | n/a | $20.69 | - | 15 | Jun 10, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | n/a | $12.98 | - | 21 | Jun 8, 2026 | |
| AUTL Autolus Therapeutics | Maintained: Buy | n/a | $1.56 | - | 40 | Jun 2, 2026 | |
| JSPR Jasper Therapeutics | Maintained: Hold | n/a | $0.466 | - | 18 | Jun 1, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | n/a | $16.06 | - | 5 | Jun 1, 2026 | |
| GMAB Genmab | Maintained: Buy | n/a | $25.24 | - | 21 | May 19, 2026 | |
| UPB Upstream Bio | Maintained: Buy | n/a | $6.38 | - | 20 | May 19, 2026 | |
| INSM Insmed | Maintained: Buy | n/a | $96.72 | - | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.42 | - | 10 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.05 | - | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.73 | - | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.71 | - | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $14 | $13.68 | +2.34% | 18 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $898.94 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $30.24 | - | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $13 | $12.09 | +7.53% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.01 | - | 7 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $354.06 | - | 38 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $56.90 | - | 58 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $203 | $224.77 | -9.69% | 9 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $253.77 | - | 1 | Jan 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $73.82 | +58.17% | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $76.45 | - | 1 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.39 | - | 19 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.34 | - | 8 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $445.04 | - | 1 | Jun 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $49.64 | n/a | 1 | Jun 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.25 | n/a | 5 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.99 | n/a | 11 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.2 | $13.07 | n/a | 1 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9256 | n/a | 13 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $106.38 | n/a | 19 | Jan 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.40 | n/a | 14 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.0003 | n/a | 11 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.04 | n/a | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $199.96 | n/a | 26 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.21 | n/a | 1 | Jun 11, 2021 |
Incyte
Jun 11, 2026
Maintained: Hold
Price Target: n/a
Current: $107.83
Upside: -
Climb Bio
Jun 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.91
Upside: -
Evommune
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $20.69
Upside: -
Cullinan Therapeutics
Jun 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $12.98
Upside: -
Autolus Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $1.56
Upside: -
Jasper Therapeutics
Jun 1, 2026
Maintained: Hold
Price Target: n/a
Current: $0.466
Upside: -
Jade Biosciences
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $16.06
Upside: -
Genmab
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $25.24
Upside: -
Upstream Bio
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $6.38
Upside: -
Insmed
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $96.72
Upside: -
May 18, 2026
Maintained: Buy
Price Target: n/a
Current: $1.42
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.05
Upside: -
May 12, 2026
Maintained: Buy
Price Target: n/a
Current: $10.73
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $5.71
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $71 → $14
Current: $13.68
Upside: +2.34%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $898.94
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $30.24
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $13 → $13
Current: $12.09
Upside: +7.53%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $2.01
Upside: -
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $354.06
Upside: -
Apr 30, 2026
Maintained: Hold
Price Target: n/a
Current: $56.90
Upside: -
Apr 29, 2026
Reiterated: Buy
Price Target: $203
Current: $224.77
Upside: -9.69%
Jan 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $253.77
Upside: -
Oct 11, 2025
Reiterated: Buy
Price Target: $117
Current: $73.82
Upside: +58.17%
Sep 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $76.45
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $3.39
Upside: -
Aug 29, 2025
Rated: Hold
Price Target: n/a
Current: $12.34
Upside: -
Jun 28, 2025
Reiterated: Buy
Price Target: n/a
Current: $445.04
Upside: -
Jun 7, 2025
Reiterated: Hold
Price Target: n/a
Current: $49.64
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.25
Upside: n/a
Apr 25, 2025
Rated: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
Mar 29, 2025
Initiated Coverage: Buy
Price Target: $1.2
Current: $13.07
Upside: n/a
Dec 29, 2022
Rated: Hold
Price Target: n/a
Current: $0.9256
Upside: n/a
Jan 3, 2022
Maintained: Buy
Price Target: n/a
Current: $106.38
Upside: n/a
Dec 7, 2021
Maintained: Buy
Price Target: n/a
Current: $10.40
Upside: n/a
Dec 7, 2021
Maintained: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a
Nov 19, 2021
Maintained: Buy
Price Target: n/a
Current: $1.04
Upside: n/a
Jul 23, 2021
Rated: Buy
Price Target: n/a
Current: $199.96
Upside: n/a
Jun 11, 2021
Maintained: Buy
Price Target: n/a
Current: $59.21
Upside: n/a